特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
952827

喘息・COPDの世界市場 - 医薬品の種類別 (気管支拡張薬、抗炎症薬、併用療法)・疾患の種類別・流通チャネル別・地域別:市場規模・シェア・将来展望・機会分析

Asthma & COPD Market, By Drug Type (Bronchodilators, Anti-Inflammatories, Combination Therapies), By Disease Type, By Distribution Channel, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

出版日: | 発行: Coherent Market Insights | ページ情報: 英文 183 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.81円
喘息・COPDの世界市場 - 医薬品の種類別 (気管支拡張薬、抗炎症薬、併用療法)・疾患の種類別・流通チャネル別・地域別:市場規模・シェア・将来展望・機会分析
出版日: 2020年07月16日
発行: Coherent Market Insights
ページ情報: 英文 183 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界の喘息およびCOPD (慢性閉塞性肺疾患) の治療薬の市場について分析し、疾患・製品の概要や、市場の基本構造および促進・抑制要因、全体的な市場規模の見通し (過去3年間・今後8年間分)、医薬品の種類別・疾患の種類別・流通チャネル別・地域別の詳細動向、主要企業のプロファイル・業績・戦略計画などを調査しております。

目次

第1章 分析目的・前提条件

第2章 市場概略

  • 分析概要
  • エグゼクティブサマリー
  • COM (Coherent Opportunity Map:市場機会マップ)

第3章 市場のダイナミクス・規制・動向の分析

  • 市場のダイナミクス
    • 市場促進要因
    • 市場抑制要因
    • 市場機会
  • 影響度の分析
  • 近年の主な動き
  • 規制シナリオ
  • PEST分析
  • 新型コロナウイルス感染症 (COVID-19) の影響度の分析

第4章 世界の喘息・COPD市場:医薬品の種類別

  • イントロダクション
    • 市場シェア (最新値・予測値)
    • 対前年成長率 (YoY) (通算11年間分)
  • 部門別の詳細動向
    • 気管支拡張薬
      • 短時間作用型気管支拡張薬
      • 長時間作用型気管支拡張薬
      • 抗コリン薬
    • 抗炎症剤
      • 吸入コルチコステロイド
      • 抗ロイコトリエン
      • モノクローナル抗体
    • 併用療法

第5章 世界の喘息・COPD市場:疾患の種類別

  • イントロダクション
    • 市場シェア (最新値・予測値)
    • 対前年成長率 (YoY) (通算11年間分)
  • 部門別の詳細動向
    • 喘息
    • COPD (慢性閉塞性肺疾患)

第6章 世界の喘息・COPD市場:流通チャネル別

  • イントロダクション
    • 市場シェア (最新値・予測値)
    • 対前年成長率 (YoY) (通算11年間分)
  • 部門別の詳細動向
    • 病院薬局
      • イントロダクション
      • 市場規模とその予測、対前年成長率 (金額ベース、通算11年間分)
    • 小売薬局
    • オンライン薬局
    • ドラッグストア

第7章 世界の喘息・COPD市場:地域別

  • イントロダクション
    • 市場シェア (最新値・予測値)
    • 対前年成長率 (YoY) (通算11年間分)
  • 地域別の詳細動向
    • 北米
      • 米国
      • カナダ
    • 欧州
      • 英国
      • ドイツ
      • イタリア
      • フランス
      • スペイン
      • ロシア
      • 他の欧州諸国
    • アジア太平洋地域
      • 中国
      • インド
      • 日本
      • ASEAN諸国
      • オーストラリア
      • 韓国
      • 他のアジア太平洋地域諸国
    • ラテンアメリカ
      • ブラジル
      • メキシコ
      • アルゼンチン
      • 他のラテンアメリカ諸国
    • 中東
      • 湾岸協力会議 (GCC) 諸国
      • イスラエル
      • 他の中東諸国
    • アフリカ
      • 北部アフリカ
      • 中部アフリカ
      • 南部アフリカ

第8章 競合情勢

  • 企業プロファイル
    • AstraZeneca PLC
    • Novartis AG
    • GlaxoSmithKline plc
    • Merck & Co., Inc.
    • Verona Pharma plc
    • Regeneron Pharmaceuticals, Inc.
    • Boehringer Ingelheim GmbH

第9章 付録

目次

Asthma is a type of chronic respiratory disease, which is characterized by attacks of breathlessness and wheezing. Asthma can occur at any stage, though it is the most common disease in children. Asthma attacks are linked to respiratory infections and environmental factors such as allergens, tobacco, smoke, and indoor and outdoor pollution. Indoor pollution factors include mold, chemicals, strong odors, and house dust whereas outdoor pollution factors include air pollution, allergens, tobacco, and smoking. Such factors are responsible for development and exacerbation of asthma.

Restraints of the Global Asthma and COPD Market

Major factors hampering the growth of the asthma and COPD market during the forecast period constitutes of patent losses, and high costs.

Key features of the study:

  • This report provides in-depth analysis of the global asthma and COPD market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2019-2027), considering 2018, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
  • It profiles leading players in the global asthma and COPD market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include AstraZeneca, Novartis AG, GlaxoSmithKline plc, Merck & Co., Verona Pharma plc,, Regeneron Pharmaceuticals, Inc., GlaxoSmithKline plc, and Boehringer Ingelheim GmbH.
  • Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global asthma and COPD market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

  • Global Asthma and COPD Market, By Drug Type:
    • Bronchodilators
  • Short Acting Bronchodilators
  • Long Acting Bronchodilators
  • Anticholinergics
    • Anti-Inflammatories
  • Inhaled Corticosteroids
  • Anti-Leukotriene
  • Monoclonal Antibodies
    • Combination Therapies
  • Global Asthma and COPD Market, By Disease Type:
    • Asthma
    • COPD
  • Global Asthma and COPD Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • Drug Stores
  • Global Asthma and COPD Market, By Geography:
    • North America
  • By Drug Type
    • Bronchodilators
      • Short Acting Bronchodilators
      • Long Acting Bronchodilators
      • Anticholinergics
    • Anti-Inflammatories
      • Inhaled Corticosteroids
      • Anti-Leukotriene
      • Monoclonal Antibodies
    • Combination Therapies
  • By Disease Type
    • Asthma
    • COPD
  • By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • Drug Stores
  • By Country:
    • U.S.
    • Canada
    • Europe
  • By Drug Type
    • Bronchodilators
      • Short Acting Bronchodilators
      • Long Acting Bronchodilators
      • Anticholinergics
    • Anti-Inflammatories
      • Inhaled Corticosteroids
      • Anti-Leukotriene
      • Monoclonal Antibodies
    • Combination Therapies
  • By Disease Type
    • Asthma
    • COPD
  • By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • Drug Stores
  • By Country:
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
  • By Drug Type
    • Bronchodilators
      • Short Acting Bronchodilators
      • Long Acting Bronchodilators
      • Anticholinergics
    • Anti-Inflammatories
      • Inhaled Corticosteroids
      • Anti-Leukotriene
      • Monoclonal Antibodies
    • Combination Therapies
  • By Disease Type
    • Asthma
    • COPD
  • By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • Drug Stores
  • By Country:
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
    • Latin America
  • By Drug Type
    • Bronchodilators
      • Short Acting Bronchodilators
      • Long Acting Bronchodilators
      • Anticholinergics
    • Anti-Inflammatories
      • Inhaled Corticosteroids
      • Anti-Leukotriene
      • Monoclonal Antibodies
    • Combination Therapies
  • By Disease Type
    • Asthma
    • COPD
  • By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • Drug Stores
  • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Middle East:
  • By Drug Type
    • Bronchodilators
      • Short Acting Bronchodilators
      • Long Acting Bronchodilators
      • Anticholinergics
    • Anti-Inflammatories
      • Inhaled Corticosteroids
      • Anti-Leukotriene
      • Monoclonal Antibodies
    • Combination Therapies
  • By Disease Type
    • Asthma
    • COPD
  • By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • Drug Stores
  • By Country:
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
  • By Drug Type
    • Bronchodilators
      • Short Acting Bronchodilators
      • Long Acting Bronchodilators
      • Anticholinergics
    • Anti-Inflammatories
      • Inhaled Corticosteroids
      • Anti-Leukotriene
      • Monoclonal Antibodies
    • Combination Therapies
  • By Disease Type
    • Asthma
    • COPD
  • By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • Drug Stores
  • By Country/Region:
    • Central Africa
    • South Africa
    • North Africa
  • Company Profiles
    • AstraZeneca PLC*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Key Strategies
  • Recent Developments
    • Novartis AG
    • GlaxoSmithKline plc
    • Merck & Co., Inc.
    • Verona Pharma plc
    • Regeneron Pharmaceuticals, Inc.
    • Boehringer Ingelheim GmbH

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

    • Research Objectives
    • Assumptions
    • Abbreviations

2. Market Purview

    • Report Description
  • Market Definition and Scope
    • Executive Summary
  • Market Snippet, By Drug Type
  • Market Snippet, By Disease Type
  • Market Snippet, By Distribution Channel
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
    • Impact Analysis
    • Key Developments
    • Regulatory Scenario
    • PEST Analysis
    • COVID-19 Impact Analysis

4. Global Asthma and COPD Market, By Drug Type, 2019 - 2027 (US$ Mn)

    • Introduction
  • Market Share Analysis, 2019 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • Bronchodilators
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Segment Trends
    • Short Acting Bronchodilators
    • Long Acting Bronchodilators
    • Anticholinergics
    • Anti-Inflammatories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Segment Trends
    • Inhaled Corticosteroids
    • Anti-Leukotriene
    • Monoclonal Antibodies
    • Combination Therapies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Segment Trends

5. Global Asthma and COPD Market, By Disease Type, 2019 - 2027 (US$ Mn)

    • Introduction
  • Market Share Analysis, 2019 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • Asthma
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • COPD
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

6. Global Asthma and COPD Market, By Distribution Channel, 2019 - 2027 (US$ Mn)

    • Introduction
  • Market Share Analysis, 2019 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Drug Stores
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

7. Global Asthma and COPD Market, By Regions, 2019 - 2027 (US$ Mn)

    • Introduction
  • Market Share Analysis, 2019 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • U.S.
    • Canada
    • Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
    • Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

    • Company Profiles
  • AstraZeneca PLC
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Novartis AG
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • GlaxoSmithKline plc
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merck & Co., Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Verona Pharma plc
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Regeneron Pharmaceuticals, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Boehringer Ingelheim GmbH
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

9. Section

    • References
    • Research Methodology
    • About us and Sales Contact
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.